{"id":"https://openalex.org/W2126948348","doi":"https://doi.org/10.1200/jco.2007.13.4015","title":"Duration of First-Line Chemotherapy in Advanced Non\u2013Small-Cell Lung Cancer: Less Is More in the Era of Effective Subsequent Therapies","display_name":"Duration of First-Line Chemotherapy in Advanced Non\u2013Small-Cell Lung Cancer: Less Is More in the Era of Effective Subsequent Therapies","publication_year":2007,"publication_date":"2007-11-16","ids":{"openalex":"https://openalex.org/W2126948348","doi":"https://doi.org/10.1200/jco.2007.13.4015","mag":"2126948348","pmid":"https://pubmed.ncbi.nlm.nih.gov/18024862"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.13.4015","doi":"https://doi.org/10.1200/jco.2007.13.4015","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.13.4015","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014554706","display_name":"Thomas E. Stinchcombe","orcid":"https://orcid.org/0000-0002-3595-8011","observed_orcids":["https://orcid.org/0000-0002-3595-8011"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas E. Stinchcombe","raw_affiliation_strings":["Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"33","first_page":"5155","last_page":"5157"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.6416000127792358,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.6416000127792358,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.353300005197525,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/cisplatin-based-chemotherapy","display_name":"cisplatin-based chemotherapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.5799999833106995},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8889999985694885},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.7549999952316284},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.7049999833106995},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.902999997138977},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.5839999914169312},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.8199999928474426},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.6579999923706055},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.5329999923706055},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9158892631530762},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6636523008346558},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.63618403673172},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5335785746574402},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45672377943992615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45075294375419617},{"id":"https://openalex.org/C112758219","wikidata":"https://www.wikidata.org/wiki/Q16038819","display_name":"Duration (music)","level":2,"score":0.4104440212249756},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2007.13.4015","doi":"https://doi.org/10.1200/jco.2007.13.4015","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.13.4015","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:18024862","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18024862","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Comment"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1924428325","https://openalex.org/W1992609848","https://openalex.org/W2020003033","https://openalex.org/W2043696829","https://openalex.org/W2052335855","https://openalex.org/W2077383408","https://openalex.org/W2099659039","https://openalex.org/W2128082578","https://openalex.org/W2130652363","https://openalex.org/W2131988196","https://openalex.org/W2134667653","https://openalex.org/W2138297714","https://openalex.org/W2145653040","https://openalex.org/W2145835533","https://openalex.org/W2153477391","https://openalex.org/W2154442955","https://openalex.org/W2161821474","https://openalex.org/W2166164739","https://openalex.org/W2203701921","https://openalex.org/W2504684570","https://openalex.org/W2589127809","https://openalex.org/W4239714259","https://openalex.org/W4251309185"],"related_works":["https://openalex.org/W2807650999","https://openalex.org/W2414249691","https://openalex.org/W2140355020","https://openalex.org/W2184873654","https://openalex.org/W1986805539","https://openalex.org/W2416211740","https://openalex.org/W2412652121","https://openalex.org/W2052135244","https://openalex.org/W2157287050","https://openalex.org/W2416876434"],"abstract_inverted_index":{"The":[0,59,112,443,469],"treatment":[1,96,185,267,286,316,566,576,686],"of":[2,52,86,97,151,159,172,180,186,202,207,212,246,266,271,297,317,352,365,420,439,445,463,477,497,550,575,589,614,617,625,634,679,743,766],"advanced,":[3],"metastatic":[4],"stage":[5,673],"IIIB/IV":[6,190,534,674],"non\u2013":[7],"small-cell":[8],"lung":[9,366],"cancer":[10,367],"(NSCLC)":[11],"has":[12,356,388,457],"come":[13],"a":[14,41,134,156,163,194,210,231,484,498,511,701],"long":[15],"way.":[16],"Fifteen":[17],"to":[18,25,69,162,256,294,370,383,451,492,494,530,556,565,579,597,610,628,653,676,737],"20":[19],"years":[20],"ago,":[21],"debate":[22],"existed":[23],"as":[24,70,78,342,648,717,719],"whether":[26],"these":[27,87,403,423,760],"stages":[28,189,533],"should":[29],"be":[30,528],"treated":[31,696],"at":[32,199,714],"all.":[33],"In":[34,100,175,278,700],"1995,":[35],"the":[36,49,82,93,138,170,173,177,200,205,208,217,243,258,261,269,280,295,315,349,363,392,405,418,453,461,474,547,561,568,573,594,608,612,615,649,662,763],"NSCLC":[37,191,621,736],"Collaborative":[38],"Group":[39],"published":[40],"meta-analysis":[42,64],"based":[43],"on":[44,458,517,723],"individual":[45],"patient":[46,569],"data,":[47],"exploring":[48],"survival":[50,105,114,122,140,262,289,407,658],"benefit":[51,115,150,690],"cisplatin-based":[53],"chemotherapy":[54],"(CBC)":[55],"in":[56,62,92,120,137,167,227,234,345,391,447,479,514,537,544,602,619,758],"this":[57,63,448,480,518,545,601],"disease.":[58,174,319],"trials":[60,215,540,761],"evaluated":[61,216],"used":[65,91],"agents":[66,220,306],"typically":[67,554,591],"referred":[68],"firstor":[71],"second-generation":[72],"agents,":[73],"and":[74,81,128,133,145,225,263,268,290,309,331,414,432,460,482,587,605,637,656],"included":[75],"drugs":[76,240],"such":[77],"mitomycin,":[79,635],"etoposide,":[80],"vinca":[83],"alkaloids;":[84],"most":[85,412,538],"are":[88,428,433],"not":[89,429,509,571,641],"commonly":[90,273],"modern":[94],"day":[95],"advanced":[98,101,346,400,620,735],"NSCLC.":[99,347,401,535],"disease,":[102],"CBC":[103,152],"improved":[104,242],"compared":[106,502,630,684],"with":[107,155,188,229,275,399,435,503,532,631,672,685,734],"best":[108],"supportive":[109],"care":[110],"(BSC).":[111],"absolute":[113],"was":[116,153,553,563,691,762],"modest":[117],"(2-month":[118],"improvement":[119,136],"median":[121,548],"time;":[123],"4":[124],"months":[125,130],"for":[126,131,143,147,299,314,397,411,693],"BSC":[127,144],"6":[129],"CBC)":[132],"10%":[135],"1-year":[139],"rate":[141],"(10%":[142],"20%":[146],"CBC).":[148],"This":[149,506],"associated":[154,434],"hazard":[157],"ratio":[158],"0.73,":[160],"translating":[161],"27%":[164],"risk":[165,270,765],"reduction":[166],"death":[168],"over":[169],"course":[171],"1997,":[176],"American":[178],"Society":[179],"Clinical":[181],"Oncology":[182],"(ASCO)":[183],"endorsed":[184],"patients":[187,398,491,531,627,671,695,705,721,733],"who":[192,706],"had":[193],"good":[195],"performance":[196],"status":[197],"(PS)":[198],"time":[201,652],"diagnosis.":[203],"Around":[204],"turn":[206],"century,":[209],"plethora":[211],"phase":[213],"III":[214],"new":[218,239],"third-generation":[219],"(paclitaxel,":[221],"docetaxel,":[222],"vinorelbine,":[223],"irinotecan,":[224],"gemcitabine)":[226],"combination":[228,250,500],"either":[230,560,738],"platinum,":[232],"or":[233,567,740,750],"novel":[235],"nonplatinum-based":[236],"doublets.":[237],"These":[238],"modestly":[241],"therapeutic":[244,343,372,393],"index":[245],"therapy,":[247],"but":[248,712],"no":[249,523,747],"seemed":[251,255],"superior.":[252],"Two-drug":[253],"combinations":[254],"optimize":[257],"balance":[259],"between":[260,661],"palliative":[264],"benefits":[265],"toxicity":[272],"seen":[274,692],"platinum-based":[276,415,455],"regimens.":[277],"1999,":[279],"first":[281,595,609],"demonstration":[282],"that":[283,359,385,487,522,559],"secondor":[284],"third-line":[285],"could":[287,570,640,707],"improve":[288,425],"palliate":[291],"symptoms":[292,465,590],"lead":[293,369],"approval":[296],"docetaxel":[298],"second-line":[300],"treatment.":[301,421,505],"Since":[302],"then,":[303],"three":[304,495,555,578,598,739],"additional":[305],"(gefitinib,":[307],"pemetrexed,":[308],"erlotinib)":[310],"have":[311,338,376,708],"been":[312,340,389],"approved":[313],"refractory":[318,564],"Recently,":[320],"two":[321,493,596,663],"important":[322,382],"biologic":[323],"pathways":[324],"(the":[325],"epidermal":[326],"growth":[327,334],"factor":[328,335],"receptor":[329],"[EGFR]":[330],"vascular":[332],"endothelial":[333],"[VEGF]":[336],"pathways)":[337],"recently":[339],"validated":[341],"targets":[344],"Lastly,":[348],"recent":[350],"discovery":[351],"EGFR":[353],"activating":[354],"mutations":[355],"created":[357],"optimism":[358],"continued":[360],"insights":[361],"into":[362],"biology":[364],"will":[368],"further":[371],"gains.":[373],"Although":[374,422],"we":[375],"much":[377,438],"work":[378],"ahead,":[379],"it":[380],"is":[381,441,450],"recognize":[384],"substantial":[386,436],"progress":[387],"made":[390],"options":[394,431],"currently":[395],"available":[396],"Despite":[402],"advances,":[404],"overall":[406,657],"profile":[408],"remains":[409],"poor":[410],"patients,":[413],"doublets":[416,424],"remain":[417],"cornerstone":[419],"survival,":[426,459,749],"they":[427],"curative":[430],"toxicity,":[437],"which":[440],"cumulative.":[442],"goal":[444],"therapy":[446,456,478,618],"setting":[449,481],"maximize":[452],"impact":[454],"palliation":[462,588],"disease-related":[464],"without":[466],"undue":[467],"toxicity.":[468],"original":[470],"ASCO":[471,520],"guidelines":[472],"addressed":[473],"appropriate":[475],"duration":[476,616],"cited":[483],"single":[485],"trial":[486,507,667,729],"randomly":[488,668,730],"assigned":[489,669,731],"74":[490],"cycles":[496,527,551,633,678,711,742],"non\u2013platinum-based":[499],"regimen":[501],"continuous":[504],"did":[508],"show":[510],"significant":[512],"difference":[513],"survival.":[515],"Based":[516],"trial,":[519],"recommended":[521],"more":[524,710],"than":[525],"eight":[526],"delivered":[529,552],"However,":[536],"clinical":[539],"evaluating":[541],"various":[542],"strategies":[543],"population,":[546],"number":[549],"four,":[557],"suggesting":[558],"disease":[562,654,675],"tolerate":[572],"toxicities":[574],"beyond":[577,697],"four":[580,677,698,715],"cycles.":[581,599,699],"Likewise,":[582],"when":[583],"reported,":[584],"objective":[585],"responses":[586],"occurred":[592],"within":[593],"With":[600],"mind,":[603],"Smith":[604],"colleagues":[606],"were":[607,659,753],"address":[611],"question":[613],"by":[622],"random":[623],"assignment":[624],"308":[626],"three,":[629],"six":[632,646,741],"vinblastine,":[636],"cisplatin.":[638],"They":[639],"demonstrate":[642],"an":[643],"advantage":[644],"from":[645],"cycles,":[647],"response":[650],"rate,":[651],"progression,":[655],"identical":[660],"arms.":[664],"A":[665,727,755,779],"second":[666],"230":[670],"carboplatin":[680,744],"plus":[681,745],"paclitaxel":[682],"(CbP),":[683],"until":[687,725],"progression.":[688,726],"No":[689],"those":[694,704,720],"subset":[702],"analysis,":[703],"received":[709],"stopped":[713],"fared":[716],"well":[718],"continuing":[722],"CbP":[724],"third":[728],"297":[732],"vinorelbine;":[746],"response,":[748],"quality-of-life":[751],"differences":[752],"demonstrated.":[754],"consistent":[756],"theme":[757],"all":[759],"increasing":[764],"cumulative":[767],"JOURNAL":[768],"OF":[769],"CLINICAL":[770],"ONCOLOGY":[771],"E":[772],"D":[773],"I":[774,778],"T":[775],"O":[776],"R":[777],"L":[780],"VOLUME":[781],"25":[782],"NUMBER":[783],"33":[784],"NOVEMBER":[785],"2":[786]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}